Key facts
- It has raised $15.6M; the latest was Later Stage VC ($11.6M) in Jan 2026.
- Notable investors include Unicorn India Ventures, Carnelian Asset Advisors, Kotak Alternate Assets Managers, Rajasthan Venture Capital Fund.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for FutureCure
- ·The full record, as it builds
Funding rounds
No funding rounds for FutureCure are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About FutureCure
Developer of specialty healthcare technologies created to help patients with migraine and other chronic diseases. The company creates wearable neuromodulation and biofeedback device technologies to diagnose and treat chronic diseases like neurological conditions, recurrent headaches, and dizziness, enabling patients to identify triggers that help manage lifestyle changes.
- Sector
- Healthcare
- HQ
- Jaipur, India
- Founded
- 2019
- Website
- futurecurehealth.com/
- Ownership
- Privately Held (backing)
FutureCure doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in FutureCure shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on FutureCure in its N-PORT filings yet. We sweep new filings monthly.